Armata Pharmaceuticals, Inc.

NYSE ARMP · Los Angeles, CA

Works in Genetic & rare · GI & liver · Infectious disease · Respiratory

Armata Pharmaceuticals, Inc. is a clinical trial sponsor based in Los Angeles, CA, listed as NYSE ARMP. It has no active clinical trials as lead sponsor; its trials since 2021 were in Genetic & rare, GI & liver, Infectious disease and Respiratory. Since 2021 it has completed 6 trials and stopped 0 early.

Trial track record · since 2021

0Active trials0 planned participants
6Completed6 with results posted
0Stopped early0% of finished trials

Financials · NYSE ARMP

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Fundraising

Pipeline · 0 active trials

No active trials with this company as lead sponsor.

Questions about Armata Pharmaceuticals, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-03-23.

Approve Suite is not affiliated with Armata Pharmaceuticals, Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.